U2Bio Co., Ltd. (KOSDAQ:221800)
South Korea · Delayed Price · Currency is KRW 3,245.00
+75.00 (2.37%)
At close: Sep 19, 2025
U2Bio Revenue
U2Bio had revenue of 6.83B KRW in the quarter ending June 30, 2025, with 0.98% growth. This brings the company's revenue in the last twelve months to 25.15B, down -4.19% year-over-year. In the year 2024, U2Bio had annual revenue of 25.04B, down -18.68%.
Revenue (ttm)
25.15B
Revenue Growth
-4.19%
P/S Ratio
1.45
Revenue / Employee
n/a
Employees
n/a
Market Cap
36.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 25.04B | -5.75B | -18.68% |
| Dec 31, 2023 | 30.79B | -38.22B | -55.38% |
| Dec 31, 2022 | 69.01B | 58.01B | 527.29% |
| Dec 31, 2014 | 11.00B | 1.59B | 16.90% |
| Dec 31, 2013 | 9.41B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |